• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼出挥发性有机化合物作为个性化医疗生物标志物的测量:重度哮喘短期重复性评估

Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma.

作者信息

Azim Adnan, Rezwan Faisal I, Barber Clair, Harvey Matthew, Kurukulaaratchy Ramesh J, Holloway John W, Howarth Peter H

机构信息

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK.

NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton SO16 6YD, UK.

出版信息

J Pers Med. 2022 Oct 2;12(10):1635. doi: 10.3390/jpm12101635.

DOI:10.3390/jpm12101635
PMID:36294774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9604907/
Abstract

The measurement of exhaled volatile organic compounds (VOCs) in exhaled breath (breathomics) represents an exciting biomarker matrix for airways disease, with early research indicating a sensitivity to airway inflammation. One of the key aspects to analytical validity for any clinical biomarker is an understanding of the short-term repeatability of measures. We collected exhaled breath samples on 5 consecutive days in 14 subjects with severe asthma who had undergone extensive clinical characterisation. Principal component analysis on VOC abundance across all breath samples revealed no variance due to the day of sampling. Samples from the same patients clustered together and there was some separation according to T2 inflammatory markers. The intra-subject and between-subject variability of each VOC was calculated across the 70 samples and identified 30.35% of VOCs to be erratic: variable between subjects but also variable in the same subject. Exclusion of these erratic VOCs from machine learning approaches revealed no apparent loss of structure to the underlying data or loss of relationship with salient clinical characteristics. Moreover, cluster evaluation by the silhouette coefficient indicates more distinct clustering. We are able to describe the short-term repeatability of breath samples in a severe asthma population and corroborate its sensitivity to airway inflammation. We also describe a novel variance-based feature selection tool that, when applied to larger clinical studies, could improve machine learning model predictions.

摘要

呼出气体中挥发性有机化合物(VOCs)的测量(呼吸组学)代表了一种用于气道疾病的令人兴奋的生物标志物基质,早期研究表明其对气道炎症具有敏感性。任何临床生物标志物分析有效性的关键方面之一是对测量短期重复性的理解。我们在14名经过广泛临床特征描述的重度哮喘患者中连续5天收集呼出气体样本。对所有呼吸样本中VOC丰度进行主成分分析,结果显示采样日之间不存在差异。来自同一患者的样本聚集在一起,并且根据T2炎症标志物存在一些分离。在70个样本中计算了每个VOC的受试者内和受试者间变异性,发现30.35%的VOC不稳定:在受试者之间可变,在同一受试者中也可变。从机器学习方法中排除这些不稳定的VOC后,未发现基础数据的结构明显损失或与显著临床特征的关系丧失。此外,通过轮廓系数进行的聚类评估表明聚类更明显。我们能够描述重度哮喘人群中呼吸样本的短期重复性,并证实其对气道炎症的敏感性。我们还描述了一种基于方差的新型特征选择工具,当应用于更大规模的临床研究时,可以改善机器学习模型的预测。

相似文献

1
Measurement of Exhaled Volatile Organic Compounds as a Biomarker for Personalised Medicine: Assessment of Short-Term Repeatability in Severe Asthma.呼出挥发性有机化合物作为个性化医疗生物标志物的测量:重度哮喘短期重复性评估
J Pers Med. 2022 Oct 2;12(10):1635. doi: 10.3390/jpm12101635.
2
Short- and medium-term effect of inhaled corticosteroids on exhaled breath biomarkers in severe asthma.吸入性皮质类固醇对严重哮喘呼气生物标志物的短期和中期影响。
J Breath Res. 2022 Jul 5;16(4). doi: 10.1088/1752-7163/ac7a57.
3
Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma.哮喘失控和临床恢复监测中的呼出气特征
Clin Exp Allergy. 2017 Sep;47(9):1159-1169. doi: 10.1111/cea.12965. Epub 2017 Jul 10.
4
Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air.哮喘儿童的呼吸道症状和呼气峰值流速与呼出气及环境空气中挥发性有机化合物的关系。
J Expo Anal Environ Epidemiol. 2003 Sep;13(5):348-63. doi: 10.1038/sj.jea.7500287.
5
Exhaled breath analysis for the discrimination of asthma and chronic obstructive pulmonary disease.呼气分析用于鉴别哮喘和慢性阻塞性肺疾病。
J Breath Res. 2024 Jul 10;18(4). doi: 10.1088/1752-7163/ad53f8.
6
Defining adult asthma endotypes by clinical features and patterns of volatile organic compounds in exhaled air.通过临床特征和呼出气体中挥发性有机化合物的模式来定义成人哮喘的内型。
Respir Res. 2014 Nov 28;15(1):136. doi: 10.1186/s12931-014-0136-8.
7
Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.使用基于宽带量子级联激光器的光谱技术对健康儿童、哮喘儿童和囊性纤维化儿童进行呼出气成分分析。
J Breath Res. 2016 Apr 8;10(2):026003. doi: 10.1088/1752-7155/10/2/026003.
8
Exhaled volatile organic compounds in adult asthma: a systematic review.成人哮喘呼出气挥发性有机化合物:系统评价。
Eur Respir J. 2019 Sep 29;54(3). doi: 10.1183/13993003.00056-2019. Print 2019 Sep.
9
Can exhaled volatile organic compounds predict asthma exacerbations in children?呼出的挥发性有机化合物能否预测儿童哮喘发作?
J Breath Res. 2017 Mar 1;11(1):016016. doi: 10.1088/1752-7163/aa5a8b.
10
Breathomics from exhaled volatile organic compounds in pediatric asthma.呼出气挥发性有机化合物在儿科哮喘中的研究进展。
Pediatr Pulmonol. 2017 Dec;52(12):1616-1627. doi: 10.1002/ppul.23785. Epub 2017 Oct 30.

引用本文的文献

1
Research hotspots and frontiers of application of mass spectrometry breath test in respiratory diseases.质谱呼气试验在呼吸系统疾病中的应用研究热点与前沿
Front Med (Lausanne). 2025 Aug 13;12:1618588. doi: 10.3389/fmed.2025.1618588. eCollection 2025.
2
New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS.“呼吸组学”的新视角:使用直接注入傅里叶变换离子回旋共振质谱法对呼出气中的非挥发性有机化合物进行代谢组学分析。
Commun Biol. 2024 Mar 2;7(1):258. doi: 10.1038/s42003-024-05943-x.
3
Gaps and future directions in research on health effects of air pollution.

本文引用的文献

1
pyComBat, a Python tool for batch effects correction in high-throughput molecular data using empirical Bayes methods.pyComBat,一个使用经验贝叶斯方法进行高通量分子数据批次效应校正的 Python 工具。
BMC Bioinformatics. 2023 Dec 7;24(1):459. doi: 10.1186/s12859-023-05578-5.
2
Breathomics for the clinician: the use of volatile organic compounds in respiratory diseases.呼吸组学在临床中的应用:挥发性有机化合物在呼吸疾病中的应用
Thorax. 2021 May;76(5):514-521. doi: 10.1136/thoraxjnl-2020-215667. Epub 2021 Jan 7.
3
Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
空气污染对健康影响的研究中的差距和未来方向。
EBioMedicine. 2023 Jul;93:104668. doi: 10.1016/j.ebiom.2023.104668. Epub 2023 Jun 23.
与哮喘诊断和疾病特征相关的挥发性有机化合物——系统评价。
Respir Med. 2020 Aug;169:105984. doi: 10.1016/j.rmed.2020.105984. Epub 2020 May 16.
4
Exhaled volatile organic compounds in adult asthma: a systematic review.成人哮喘呼出气挥发性有机化合物:系统评价。
Eur Respir J. 2019 Sep 29;54(3). doi: 10.1183/13993003.00056-2019. Print 2019 Sep.
5
Protocol for the Wessex AsThma CoHort of difficult asthma (WATCH): a pragmatic real-life longitudinal study of difficult asthma in the clinic.威塞克斯哮喘队列研究方案(WATCH):一项在临床中对难治性哮喘进行的实用真实纵向研究。
BMC Pulm Med. 2019 May 24;19(1):99. doi: 10.1186/s12890-019-0862-2.
6
Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma.呼出气挥发性有机化合物可区分中性粒细胞性和嗜酸性粒细胞性哮喘。
Am J Respir Crit Care Med. 2019 Aug 15;200(4):444-453. doi: 10.1164/rccm.201811-2210OC.
7
Toward clinically applicable biomarkers for asthma: An EAACI position paper.迈向哮喘临床适用生物标志物:一项 EAACI 立场文件。
Allergy. 2019 Oct;74(10):1835-1851. doi: 10.1111/all.13806.
8
Stratification of asthma phenotypes by airway proteomic signatures.气道蛋白质组特征对哮喘表型的分层。
J Allergy Clin Immunol. 2019 Jul;144(1):70-82. doi: 10.1016/j.jaci.2019.03.013. Epub 2019 Mar 28.
9
Biomarkers in asthma: state of the art.哮喘中的生物标志物:最新进展
Asthma Res Pract. 2018 Dec 21;4:10. doi: 10.1186/s40733-018-0047-4. eCollection 2018.
10
Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project.大规模呼气分析研究的方法学考虑因素:来自 U-BIOPRED 严重哮喘项目的经验教训。
J Breath Res. 2018 Oct 30;13(1):016001. doi: 10.1088/1752-7163/aae557.